Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
6
SFDA:5
NPRA:1
Drug Approvals
KRABEVA Bevacizumab (r-DNA Origin) Concentrate for Solution for Intravenous Infusion 25mg/mL
- Approval Date
- Jul 7, 2025
- Company
- biocon sdn bhd
NPRA
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)No trials found
News
No news found